Insight Molecular Diagnostics Inc. Operating Lease, Payments
Insight Molecular Diagnostics Inc. (IMDX) reported Operating Lease, Payments of $665.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-08-10
- Insight Molecular Diagnostics Inc. operating lease, payments for the quarter ending 2026-06-30 was $335.00K, a 17.13% increase year-over-year.
- Insight Molecular Diagnostics Inc. operating lease, payments for the quarter ending 2026-03-31 was $330.00K, a 17.44% increase year-over-year.
- Insight Molecular Diagnostics Inc. operating lease, payments for the quarter ending 2025-12-31 was $329.00K, a 17.92% increase year-over-year.
- Insight Molecular Diagnostics Inc. operating lease, payments for the quarter ending 2025-09-30 was $288.00K, a 3.23% increase year-over-year.
- Insight Molecular Diagnostics Inc. operating lease, payments for fiscal 2025 was $1.18M, a 7.05% increase from fiscal 2024.
- Insight Molecular Diagnostics Inc. operating lease, payments for fiscal 2024 was $1.11M, a 5.53% increase from fiscal 2023.
- Insight Molecular Diagnostics Inc. operating lease, payments for fiscal 2023 was $1.05M, a 8.31% decline from fiscal 2022.
- Insight Molecular Diagnostics Inc. operating lease, payments for fiscal 2022 was $1.14M, a 9.69% increase from fiscal 2021.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $335.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $665.00K 10-Q · filed 2026-08-10 | $994.00K derived: sum of 3 quarters · filed 2026-08-10 | $1.28M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $330.00K 10-Q · filed 2026-05-13 | $659.00K derived: sum of 2 quarters · filed 2026-05-13 | $947.00K derived: sum of 3 quarters · filed 2026-05-13 | $1.23M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $329.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $617.00K derived: sum of 2 quarters · filed 2026-03-26 | $903.00K derived: sum of 3 quarters · filed 2026-08-10 | $1.18M 10-K · filed 2026-03-26 |
| 2025-09-30 | $288.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $574.00K derived: sum of 2 quarters · filed 2026-08-10 | $855.00K 10-Q · filed 2025-11-10 | $1.13M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $286.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $567.00K 10-Q · filed 2026-08-10 | $846.00K derived: sum of 3 quarters · filed 2026-08-10 | $1.13M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $281.00K 10-Q · filed 2026-05-13 | $560.00K derived: sum of 2 quarters · filed 2026-05-13 | $839.00K derived: sum of 3 quarters · filed 2026-05-13 | $1.11M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $279.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $558.00K derived: sum of 2 quarters · filed 2026-03-26 | $834.00K derived: sum of 3 quarters · filed 2026-03-26 | $1.11M 10-K · filed 2026-03-26 |
| 2024-09-30 | $279.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $555.00K derived: sum of 2 quarters · filed 2025-11-10 | $827.00K 10-Q · filed 2025-11-10 | $1.08M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $276.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $548.00K 10-Q · filed 2025-08-11 | $803.00K derived: sum of 3 quarters · filed 2025-08-11 | $1.06M derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $272.00K 10-Q · filed 2025-05-12 | $527.00K derived: sum of 2 quarters · filed 2025-05-12 | $782.00K derived: sum of 3 quarters · filed 2025-05-12 | $1.03M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $255.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $510.00K derived: sum of 2 quarters · filed 2025-03-24 | $762.00K derived: sum of 3 quarters · filed 2025-03-24 | $1.05M 10-K · filed 2025-03-24 |
| 2023-09-30 | $255.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $507.00K derived: sum of 2 quarters · filed 2024-11-12 | $793.00K 10-Q · filed 2024-11-12 | $1.08M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $252.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $538.00K 10-Q · filed 2024-08-08 | $827.00K derived: sum of 3 quarters · filed 2024-08-08 | $1.12M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $286.00K 10-Q · filed 2024-05-15 | $575.00K derived: sum of 2 quarters · filed 2024-05-15 | $865.00K derived: sum of 3 quarters · filed 2024-05-15 | $1.15M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $289.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $579.00K derived: sum of 2 quarters · filed 2024-04-16 | $866.00K derived: sum of 3 quarters · filed 2024-04-16 | $1.14M 10-K · filed 2024-04-16 |
| 2022-09-30 | $290.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $577.00K derived: sum of 2 quarters · filed 2023-11-09 | $854.00K 10-Q · filed 2023-11-09 | $1.13M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $287.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $564.00K 10-Q · filed 2023-08-10 | $841.00K derived: sum of 3 quarters · filed 2023-08-10 | $1.11M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $277.00K 10-Q · filed 2023-05-15 | $554.00K derived: sum of 2 quarters · filed 2023-05-15 | $820.00K derived: sum of 3 quarters · filed 2023-05-15 | $1.10M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $277.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-12 | $543.00K derived: sum of 2 quarters · filed 2023-04-12 | $822.00K derived: sum of 3 quarters · filed 2023-04-12 | $1.04M 10-K · filed 2023-04-12 |
| 2021-09-30 | $266.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $545.00K derived: sum of 2 quarters · filed 2022-11-10 | $765.00K 10-Q · filed 2022-11-10 | $954.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $279.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $499.00K 10-Q · filed 2022-08-12 | $688.00K derived: sum of 3 quarters · filed 2022-08-12 | $877.00K derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $220.00K 10-Q · filed 2022-05-12 | $409.00K derived: sum of 2 quarters · filed 2022-05-12 | $598.00K derived: sum of 3 quarters · filed 2022-05-12 | $694.00K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $189.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $378.00K derived: sum of 2 quarters · filed 2022-03-11 | $474.00K derived: sum of 3 quarters · filed 2022-03-11 | $552.00K 10-K · filed 2022-03-11 |
| 2020-09-30 | $189.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $285.00K derived: sum of 2 quarters · filed 2021-08-11 | $363.00K 10-Q · filed 2020-11-12 | $368.00K derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-06-30 | $96.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $174.00K 10-Q · filed 2021-08-11 | $179.00K derived: sum of 3 quarters · filed 2021-08-11 | $187.00K derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | $78.00K 10-Q · filed 2021-05-17 | $83.00K derived: sum of 2 quarters · filed 2021-05-17 | $91.00K derived: sum of 3 quarters · filed 2021-05-17 | $101.00K derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $13.00K derived: sum of 2 quarters · filed 2020-11-12 | $23.00K derived: sum of 3 quarters · filed 2020-11-12 | $35.00K 10-K · filed 2020-03-26 |
| 2019-09-30 | $8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $18.00K derived: sum of 2 quarters · filed 2020-11-12 | $30.00K 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $22.00K 10-Q · filed 2020-07-29 | ||
| 2019-03-31 | $12.00K 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |